๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Changes in negative symptoms and the risk of tardive dyskinesia: A longitudinal study

โœ Scribed by J. van Os; E. Walsh; E. van Horn; T. Tattan; R. Bale; S.G. Thompson

Book ID
119554490
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
108 KB
Volume
41
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A pilot study of verapamil in the treatm
A pilot study of verapamil in the treatment of tardive dyskinesia
โœ Timothy G. Dinan; Claire Capstick ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB ๐Ÿ‘ 1 views

Six patients with severe and stable tardive dyskinesia were treated with verapamil, a calcium channel blocker, in doses ranging from 240 to 400 mg/day. Weekly assessments were made using the Simpson tardive dyskinesia rating scale. Neuroleptic medication was held constant during the 3-month baseline